{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-157373","form_type":"8-K/A","ticker":"LYRA","cik":"0001327273","company_name":"Lyra Therapeutics, Inc.","filed_at":"2024-06-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:17.906898+00:00","generated_at":"2026-06-01T05:30:01.932132+00:00","sec_items":["2.05"],"event_type":"other_material","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Lyra Therapeutics estimates $3.9-4.1M in charges from workforce reduction of up to 87 employees","bullets":["Board approved workforce reduction of up to 87 employees, effective May 21 and June 20, 2024.","Cost estimate: $3.9 to $4.1 million, primarily severance and benefits.","Majority of charges expected in Q2 2024.","Company previously could not estimate costs; this 8-K/A provides updated disclosure."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-157373","json":"https://secwatch.observer/filing/0001193125-24-157373.json","markdown":"https://secwatch.observer/filing/0001193125-24-157373.md","text":"https://secwatch.observer/filing/0001193125-24-157373.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1327273/000119312524157373/0001193125-24-157373-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1327273/000119312524157373/d837500d8ka.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T05:30:01.932132+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"0063173ccd874b6b874025fb557f20247bc9f096","claim":"Lyra Therapeutics, Inc. announced a restructuring with charges of approximately $3.9 to $4.1 million (up to 87 employees).","evidence_excerpt":"The Company currently estimates that it will incur charges of approximately $3.9 to $4.1 million in connection with the Workforce Reduction, primarily consisting of severance payments, employee benefits and related costs.","evidence_source":"SEC 8-K Item 2.05/2.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1327273/000119312524157373/0001193125-24-157373-index.htm","confidence":0.9,"family_label":"Restructurings & Charges","details":[{"label":"Type","value":"restructuring"},{"label":"Charge","value":"approximately $3.9 to $4.1 million"},{"label":"Headcount","value":"up to 87 employees"}],"fact_type":"restructuring_charge"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}